🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Anti-PD-1

Found 2014 matching trials

STRIVE: A Single-arm Phase 2 Study on Treatment of Lung Squamous Cell Carcinoma by Tiragolumab Plus Ivonescimab for Patients Who Progressed on Platinum Doublets and Anti-PD-1/PD-L1

PHASE2

To learn if the drug combination of tiragolumab and ivonescimab can help to...

Status

Withdrawn

Location

Multiple Locations

Start Date

2025-07-28

Trial ID

NCT07038915

Treatments Being Tested

Tiragolumab Ivonescimab

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Kidney Cancer

PHASE2

This is a phase II Randomized comparison clinical trial of activated CIK ar...

Status

Withdrawn

Location

Institutional Review Board of Guangzhou Fuda Cancer Hospital

Start Date

2018-04-10

Trial ID

NCT03540199

Treatments Being Tested

Activated CIK and CD3-MUC1 Bispecific Antibody in Treating Kidney Cancer cryotherapy

Safety, Tolerability and Preliminary Efficacy of Erythrocyte-αPD-1 Conjugate in Patients With Advanced Malignancies

PHASE1

This is an investigator-initiated, multi-center, open-label clinical study ...

Status

Not Yet Recruiting

Location

Multiple Locations

Start Date

2024-07-31

Trial ID

NCT06528249

Treatments Being Tested

Engineered erythrocytes (or red blood cells) covalently conjugated with commercially available anti-PD-1 antibodies on their membranes

CGA Guided Ultrafractionated RT and First-line Systemic Treatment in Elderly or Frail Patients with MCRC

PHASE2

This is a prospective, multicentre, cohort study. For cohort 1(CGA cohort),...

Status

Not Yet Recruiting

Location

Multiple Locations

Start Date

2024-11

Trial ID

NCT06665087

Treatments Being Tested

Ultrafractionated RT and CGA Guided systemic treatment.Ultrafractionated Radiotherapy PD-1 antibody Chemotherapy (Fluorouracil)Chemotherapy (Raltitrexed)Chemotherapy (Oxaliplatin)Chemotherapy (CPT-11)Targeted Therapy (anti-VEGF)Targeted Therapy (anti-EGFR)

Research on Intelligent Screening and Decision-making for Neoadjuvant Therapy in Locally Advanced Gastric Cancer Based on Multi-omics Integration

N/A

In this study, investigators utilize a radiopathomics integrated Artificial...

Status

Unknown

Location

Gastrointestinal Department of First Affiliated Hospital of Zhejiang University

Start Date

2024-07-01

Trial ID

NCT06396143

Assessment of Safety and Preliminary Efficacy With BAT6021 in Solid Tumor Patients

PHASE1

This first-in-human open-label, multi center, dose-escalation and expansion...

Status

Terminated

Location

Liverpool Hospital

Start Date

2021-10-29

Trial ID

NCT05073484

Treatments Being Tested

BAT6021 BAT1308

Safety and Efficacy of Intra-Arterial and Intra-Tumoral Ad-p53 With Capecitabine (Xeloda) or Anti-PD-1 in Liver Metastases of Solid Tumors and Recurrent Head and Neck Squamous Cell Cancer

PHASE1

This is a Phase 1/2 study of the combination of Ad-p53 administered intra-a...

Status

Terminated

Location

MD Anderson Cancer Center

Start Date

2018-11-20

Trial ID

NCT02842125

Treatments Being Tested

Ad-P53 Xeloda Keytruda Opdivo

Phase 1/2 Study of TU2218 Alone and in Combination With Checkpoint Inhibitors in Patients With Advanced Solid Tumors

PHASE1

This study consists of Part A for monotherapy and Part B for combination th...

Status

Recruiting

Location

NEXT Oncology

Start Date

2021-12-02

Trial ID

NCT05204862

Treatments Being Tested

TU2218 Anti-PD-1 antibody

A Phase 1b Study of Atezolizumab in Combination With Vemurafenib or Vemurafenib Plus Cobimetinib in Participants With BRAFV600-Mutation Positive Metastatic Melanoma

PHASE1

This is an open-label, multicenter, Phase Ib, dose-escalation and cohort-ex...

Status

Completed

Location

UCLA

Start Date

2012-08-13

Trial ID

NCT01656642

Treatments Being Tested

Atezolizumab Cobimetinib Vemurafenib

Perioperative Therapy for Hepatocellular Carcinoma

PHASE2

This study aims to observe and evaluate the efficacy and safety of the peri...

Status

Terminated

Location

the First Affiliated Hospital, School of Medicine, Zhejiang University

Start Date

2020-12-26

Trial ID

NCT04653389

Treatments Being Tested

Sintilimab Injection TACE Radiotherapy

Previous Next